๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Immune Response and Myoblasts That Express Fas Ligand

โœ Scribed by Kang, S.

Book ID
121158674
Publisher
American Association for the Advancement of Science
Year
1997
Tongue
English
Weight
381 KB
Volume
278
Category
Article
ISSN
0036-8075

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Cholangiocarcinomas express fas ligand a
Cholangiocarcinomas express fas ligand and disable the fas receptor
โœ Florencia G. Que; Vy A. Phan; Van H. Phan; Adrianne Celli; Kenneth Batts; Nichol ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 326 KB

Cholangiocarcinoma is a highly-malignant adenocarcinoma originating from cholangiocytes. Current concepts support escape from immune surveillance using aberrant expression of Fas ligand (FasL) and dysregulation of receptor (FasR) signaling as a potential mechanism for tumor progression. Our aims wer

Fas ligand and immune evasion
Fas ligand and immune evasion
โœ Nagata, Shigekazu ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 319 KB
Activated B cells express functional Fas
Activated B cells express functional Fas ligand
โœ Michael Hahne; Toufic Renno; Michael Schroeter; Martin Irmler; Lars French; Thie ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 425 KB

## Abstract Fas ligand (FasL, Apoโ€1L) is a member of the tumor necrosis factor protein family and binding to its receptor (Fas, Apoโ€1, CD95) triggers cell death through apoptosis. Ligand expression is restricted to cells with known cytolytic activity and found on hematopoietic cells of the T cell a